While rare cases of idiosyncratic drug-induced liver injury have been reported, there is no established direct link between GLP-1 receptor agonists and serious hepatotoxicity in patients with normal baseline liver function
Setmelanotide is currently being studied for treatment of acquired hypothalamic obesity (HO), a condition occurring after injury to the relevant satiety centers, also characterized by hyperphagia and rapid weight gain
Metabolites can serve as potential prevention and treatment targets for preeclampsia
Qualitatively, rodents and humans have very similar responses to surgery
James SJ, Rose S, Melnyk S, Jernigan S, Blossom S, Pavliv O (2009) Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells derived from children with autism
Understanding the current peptide regulatory landscape helps contextualize these timelines, as regulatory agencies worldwide are moving at different speeds on GLP-1 approvals